Leapcure

Leapcure specializes in data-driven, tech-enabled patient recruitment to make clinical trials more equitable and efficient. It has supported over 130 studies in more than 50 countries with consistently high enrollment rates (>50%). The company’s offerings include IND feasibility assessments, study startup support, site selection assistance, public awareness campaigns through a network of over 12,000 advocacy groups globally, and integrated digital tools to streamline trial participation. Its acquisition of Honeybee Trials further expanded its capabilities in decentralized trials and self-service recruitment technologies. No direct clinical results as it does not sponsor or run its own interventional programs.